By Sherri Oslick --
About Court Report: Each week we will report briefly on recently filed biotech and pharma cases.
Pfizer Inc., et al.v. Mylan Inc. et al.
1:10-cv-06463; filed August 20, 2010 in the Southern District of New York
• Plaintiffs: Pfizer Inc.; Pfizer Products Inc.; C.P. Pharmaceuticals International C.V.
• Defendants: Mylan Inc.; Mylan Pharmaceuticals Inc.
Infringement of U.S. Patent Nos. 7,265,119 ("Tartrate Salts of 5,8,14-Triazatetracyclo[10.3.1.02,11.04.9]- Hexadeca-2(11),3,5,7,9-Pentaene and Pharmaceutical Compositions Thereof," issued September 4, 2007) and 6,890,927 (same title, issued May 20, 2005) following a Paragraph IV certification as part of Mylan's filing of an ANDA to manufacture a generic version of Pfizer's Chantix® (varenicline tartrate, used in the treatment of nicotine dependency, addiction, and withdrawal). View the complaint here.
Helicos Biosciences Corp. v. Pacific Biosciences of California Inc.
1:10-cv-00735; filed August 27, 2010 in the District Court of Delaware
Infringement of U.S. Patent Nos. 7,645,596 ("Method of Determining the Nucleotide Sequence of Oligonucleotides and DNA Molecules," issued January 12, 2010), 7,037,687 (same title, issued May 2, 2006), 7,169,560 ("Short Cycle Methods for Sequencing Polynucelotides," issued January 20, 2007), and 7,767,400 ("Paired-end Reads in Sequencing by Synthesis," issued August 2, 2010) based on Pacific Bioscience's manufacture and use of its Single Molecule Real Time (SMRT) DNA Sequencing technology. View the complaint here.
Comments